Target intelligence / Profile preview

UPF1 RNA helicase and ATPase (UPF1)

Target
UPF1
Molecular classification
Enzyme, RNA helicase, ATPase, RNA-binding protein
01

Overview

UPF1 RNA helicase and ATPase (UPF1) is a highly conserved, multifunctional protein that serves as the master regulator of the nonsense-mediated mRNA decay (NMD) pathway (UniProt P78347). It functions as an ATP-dependent RNA helicase that translocates along RNA to displace proteins and remodel ribonucleoprotein complexes, a process essential for the surveillance and degradation of transcripts containing premature termination codons (PubMed: 28223409). Beyond its primary role in NMD, UPF1 is involved in telomere maintenance, DNA replication stress responses, and the regulation of various RNA decay pathways (NCBI Gene: 5976). In the context of human disease, UPF1 is a target of interest in oncology, where NMD inhibition can enhance the expression of tumor-specific neoantigens, potentially sensitizing tumors to immunotherapy (PubMed: 31533975). Additionally, UPF1 modulation is explored in genetic disorders caused by nonsense mutations, where suppressing NMD may restore the expression of truncated but functional proteins (PubMed: 24532341). In neurodegenerative conditions like Amyotrophic Lateral Sclerosis (ALS), UPF1 has shown neuroprotective effects by clearing toxic RNA species (PubMed: 26300005). While no UPF1-targeted therapies are currently FDA-approved, small molecule inhibitors like NMDI-1 and antisense oligonucleotides are being utilized in preclinical research to evaluate the therapeutic potential of NMD modulation (PubChem CID: 2826652).

Other names
RENT1HUPF1NORF1Regulator of nonsense transcripts 1ATP-dependent RNA helicase UPF1
02

Mechanism of action

Inhibition of the nonsense-mediated mRNA decay (NMD) pathway by blocking UPF1 phosphorylation or its helicase activity.

03

Biological functions

Nonsense-mediated mRNA decayRNA metabolismTelomere maintenanceDNA replication stress responseViral replication regulation
04

Disease associations

CancerAmyotrophic lateral sclerosisGenetic disordersViral infection
05

Safety considerations

Systemic toxicity due to essential role in RNA surveillanceRisk of accumulating toxic truncated proteinsEmbryonic lethality in knockout modelsPotential for widespread transcriptome dysregulation
06

Interacting drugs

NMDI-1

1 more in the full profile.

07

Biomarkers

UPF1 protein expressionPhospho-UPF1 levelsNMD-target transcript levels (e.g., ATF4, GADD45)

Beyond the preview

Go deeper on UPF1 RNA helicase and ATPase (UPF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UPF1 RNA helicase and ATPase (UPF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call